Provenienza dei contatti di primo grado di Matthew Bartholomae
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Extinct | Biotechnology | 17 | |
| Public Company | Pharmaceuticals: Major | 10 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Matthew Bartholomae tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| ARQULE, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| SANOFI | Pharmaceuticals: Major | Corporate Officer/Principal | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member | |
InfaCare Pharmaceutical Corp.
 InfaCare Pharmaceutical Corp. BiotechnologyHealth Technology InfaCare Pharmaceutical Corp. develops and commercializes proprietary pharmaceuticals for the neonatal and pediatric patient population. It offers Stanate, a heme oxygenase inhibitor for the treatment of infantile jaundice or hyperbilirubinemia. The company was founded by Robert A. Vukovich on July 5, 2005 and is headquartered in Trevose, PA. | Biotechnology | Corporate Officer/Principal | |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| DNIB UNWIND INC | Biotechnology | Director/Board Member Founder | |
NormOxys, Inc.
 NormOxys, Inc. Pharmaceuticals: MajorHealth Technology NormOxys, Inc. develops small-molecule therapeutics for the treatment of cancer. Its major product is OXY111A. The company was founded by Conrad J Bletzer, Jr. Claude Nicoalu, Jean-Mearie Lehn, Gay Goodman, Ruth Greferath and Roscoe Brady in 2004 and is headquartered in Brighton, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| IPI LEGACY LIQUIDATION CO | Pharmaceuticals: Major | Director of Finance/CFO | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Masters Business Admin | |
Index Ventures SA
 Index Ventures SA Investment ManagersFinance Index Ventures SA (Index Ventures) is a venture capital firm founded in 1996 by Neil Alexander Rimer, Gluseppe Zocco and Gerald Rimer. The firm is headquartered in Geneva, Switzerland. | Investment Managers | Private Equity Analyst | |
The Brigham & Women's Hospital, Inc.
 The Brigham & Women's Hospital, Inc. Hospital/Nursing ManagementHealth Services The Brigham & Women's Hospital, Inc. provides health care services. The firm offers treatment for cancer, cardio vascular, neurosciences, orthopedic, arthritis, women's health and clinical services. The company was founded in 1980 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Masters Business Admin | |
| Elizabethtown College | College/University | Undergraduate Degree | |
| University of Wisconsin | College/University | Doctorate Degree Doctorate Degree Doctorate Degree | |
| University of California, Berkeley | College/University | Undergraduate Degree Graduate Degree | |
| University of Maryland | College/University | Undergraduate Degree Corporate Officer/Principal | |
| NanoDimension AG | Chief Executive Officer | ||
Devon Park Bioventures
 Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Investment Managers | Private Equity Investor | |
| MOLECULAR PARTNERS AG | Biotechnology | Director/Board Member Director/Board Member | |
OncoEthix SA
 OncoEthix SA Pharmaceuticals: MajorHealth Technology OncoEthix SA operates as a clinical stage biotechnology company which develops cancer drugs. Its products include OTX008, OTX015, and OTX009. The company was founded by Esteban Cvitkovic, Jeanne Kay Noel, Yves Paternot, and Patrice Herait in March 2007 and is headquartered in Luzern, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
Bristol-Myers Squibb SARL
 Bristol-Myers Squibb SARL Medical DistributorsDistribution Services Bristol-Myers Squibb SARL engages in the research, development, manufacture, and distribution of pharmaceutical products. Its therapeutic areas include immunoscience, immune-oncology, and cardiology. The company is headquartered in Rueil-Malmaison, France. | Medical Distributors | Corporate Officer/Principal | |
ProFibrix BV
 ProFibrix BV BiotechnologyHealth Technology ProFibrix BV develops and markets products for the hemostasis and regenerative medicine markets. Its product in pipeline, ProFibrix, is a hemostatic agent for mild to moderate surgical bleeding. The firm operates through its offices located in Leiden and Seattle. It is a subsidiary of The Medicines Company. The company was founded in 2004 by Jaap Koopman and is headquartered in Leiden, the Netherlands. | Biotechnology | Director/Board Member Director/Board Member | |
| Harvard Medical School | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| Oriel College | College/University | Graduate Degree | |
| The University of Chicago Booth School of Business | College/University | Masters Business Admin Masters Business Admin | |
Topokine Therapeutics, Inc.
 Topokine Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Topokine Therapeutics, Inc. develops therapies for dermatology and medical aesthetics. Its product, the XAF5 Gel, reduces excess subcutaneous fat. The XAF5 is an adipomodulatory compound that inhibits adipocytes by engaging a cell-surface receptor, resulting in down-regulation of key adipocyte transcription factors. The company was founded in 2010 and is headquartered in Madison, NJ. | Pharmaceuticals: Major | Founder Founder | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Perelman School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MIT Sloan School of Management | College/University | Masters Business Admin | |
Cartesian Therapeutics, Inc.
 Cartesian Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Cartesian Therapeutics, Inc. manufacturers biological products. The company was founded by Murat Kalayoglu and Michael Singer in 2016 and is headquartered in Gaithersburg, MD. | Miscellaneous Commercial Services | Chief Executive Officer Founder Corporate Officer/Principal Chief Executive Officer Chief Operating Officer Chief Tech/Sci/R&D Officer Chief Tech/Sci/R&D Officer | |
Morphic Therapeutic, Inc.
 Morphic Therapeutic, Inc. BiotechnologyHealth Technology Morphic Therapeutic, Inc. engages in biotechnology drug development activity. The company is headquartered in Waltham, MA. | Biotechnology | Founder Chief Tech/Sci/R&D Officer Director/Board Member | |
Scholar Rock, Inc.
 Scholar Rock, Inc. BiotechnologyHealth Technology Scholar Rock, Inc. operates as a biotechnology company. It focuses on discovering and developing a novel class of biologic therapies that target supracellular activation of growth factors in the disease microenvironment. The company was founded by Timothy Springer and Leonard Zon and is headquartered in Cambridge, MA. | Biotechnology | Founder Director/Board Member | |
Medicxi Ventures (Jersey) Ltd.
 Medicxi Ventures (Jersey) Ltd. Investment ManagersFinance Medicxi Ventures (Jersey) Ltd. (Medicxi) is an independent venture capital firm founded in 2016 by Francesco de Rubertis, Michèle Ollier, and Kevin S. Johnson. The firm is headquartered in London. | Investment Managers | Founder Founder | |
Placon Therapeutics, Inc.
 Placon Therapeutics, Inc. BiotechnologyHealth Technology Placon Therapeutics, Inc. develops novel platinum therapies. The private company is based in Watertown. | Biotechnology | Director/Board Member Director/Board Member | |
| SEER, INC. | Biotechnology | Chief Executive Officer General Counsel | |
Institute For Protein Innovation, Inc.
 Institute For Protein Innovation, Inc. Miscellaneous Commercial ServicesCommercial Services Institute For Protein Innovation, Inc. is a non-profit company that focuses on enhancing the potential of recombinant antibodies. The company is based in Boston, MA. The company uses sophisticated yeast display technology to generate synthetic, recombinant antibodies. The company was founded by Andrew Kruse, Timothy A. Springer. Kenneth Fasman has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Founder Director/Board Member | |
| MORPHIC HOLDING, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Founder Director/Board Member | |
| SENTI BIOSCIENCES, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 40 |
| Svizzera | 5 |
| Regno Unito | 4 |
| Francia | 3 |
| Paesi Bassi | 2 |
Settori
| Health Technology | 26 |
| Consumer Services | 13 |
| Commercial Services | 6 |
| Finance | 5 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 281 |
| Corporate Officer/Principal | 82 |
| Independent Dir/Board Member | 64 |
| Chairman | 56 |
| Chief Executive Officer | 43 |
Contatti più connessi
| Insiders | |
|---|---|
| Amir Nashat | 51 |
| Göran Albert Ando | 44 |
| Michèle Ollier | 40 |
| Bill Doyle | 38 |
| Francesco de Rubertis | 36 |
| Hans-Peter Hasler | 28 |
| Patrick Zenner | 24 |
| Carrie Cox | 22 |
| Timothy Barabe | 21 |
| Timothy Springer | 19 |
| Nishan de Silva | 18 |
| Scott Myers | 18 |
| Nico Vandervelpen | 17 |
| Omid Farokhzad | 15 |
| Peter Traber | 15 |
- Borsa valori
- Insiders
- Matthew Bartholomae
- Connessioni Società
